Search results for "severity"

showing 10 items of 1287 documents

Long-Term Results of Stenting of the Aortic Bifurcation

2012

Background To evaluate the long-term results in a multicentric continuous series of narrowing lesions of the aortic bifurcation treated with a kissing stent. Methods From January, 1st 1999 to the December, 31st 2001, all of the patients ( n = 80) presenting with stenosis of the aortic bifurcation ( n = 15) and/or the 2 common iliac arteries ( n = 65), treated with a kissing stent, in 8 teaching hospitals were collected retrospectively. The risk factors were smoking (91%), dyslipidemia (60%), arterial hypertension (42%) and diabetes (27%). In 84% of cases, the indication for treatment was claudication. The lesions were stenotic n = 76) and/or thrombotic ( n = 18). The associated lesions were…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationArterial Occlusive DiseasesDissection (medical)Iliac ArterySeverity of Illness IndexDiagnosis DifferentialBlood Vessel Prosthesis Implantationmedicine.arteryAngioplastymedicineHumansAorta AbdominaleducationRetrospective StudiesAortaeducation.field_of_studybusiness.industryStentGeneral MedicineAortic bifurcationMiddle Agedmedicine.diseaseSurgeryFemoral ArteryStenosisTreatment Outcomemedicine.anatomical_structureFemaleStentsSurgeryRadiologymedicine.symptomTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessClaudicationMagnetic Resonance AngiographyFollow-Up StudiesAnnals of Vascular Surgery
researchProduct

The relation between the incidence of hypernatremia and mortality in patients with severe traumatic brain injury

2009

Introduction The study was aimed at verifying whether the occurrence of hypernatremia during the intensive care unit (ICU) stay increases the risk of death in patients with severe traumatic brain injury (TBI). We performed a retrospective study on a prospectively collected database including all patients consecutively admitted over a 3-year period with a diagnosis of TBI (post-resuscitation Glasgow Coma Score ≤ 8) to a general/neurotrauma ICU of a university hospital, providing critical care services in a catchment area of about 1,200,000 inhabitants. Methods Demographic, clinical, and ICU laboratory data were prospectively collected; serum sodium was assessed an average of three times per …

Malemedicine.medical_specialtyTraumatic brain injuryCritical Care and Intensive Care MedicineSeverity of Illness Indexlaw.inventionHospitals UniversitylawSeverity of illnessmedicineHumansDeamino Arginine VasopressinIntensive care medicineProportional Hazards ModelsRetrospective StudiesSaline Solution HypertonicHypernatremiabusiness.industryIncidenceResearchIncidence (epidemiology)Glasgow Coma ScaleRetrospective cohort studyMiddle Agedmedicine.diseaseIntensive care unitHypertonic salineIntensive Care UnitsBrain InjuriesEmergency medicineCommentaryFemaleHypernatremiaIntracranial HypertensionbusinessCritical Care
researchProduct

Femoropopliteal prosthetic bypass with glutaraldehyde stabilized human umbilical vein (HUV).

2007

Objective Femoropopliteal bypass still is the standard surgical therapy for disabling claudication and critical ischemia. When autologous vein is not suitable synthetic or biological prostheses may be considered. Second generation glutaraldehyde tanned human umbilical vein (HUV) graft was chosen for above and below knee femoropopliteal bypass when autologous vein was not available. A single center experience regarding long-term graft function, secondary reinterventions, and potential biodegeneration of the HUV is presented. Methods Between January 1994 and January 2005, 211 consecutive femoropopliteal bypass operations with HUV (65 above knee and 146 below knee) were performed in 197 patien…

Malemedicine.medical_specialtyUmbilical VeinsTime FactorsTissue FixationAnastomosisProsthesis DesignSeverity of Illness IndexBlood Vessel Prosthesis ImplantationFixativesAneurysmIschemiamedicineHumansPopliteal ArteryDerivationVeinVascular PatencyAgedRetrospective StudiesUltrasonographyAged 80 and overBioprosthesismedicine.diagnostic_testbusiness.industryGreat saphenous veinGraft Occlusion VascularThrombosisIntermittent ClaudicationMiddle Agedmedicine.diseaseLimb SalvageThrombosisSurgeryBlood Vessel ProsthesisFemoral Arterymedicine.anatomical_structureTreatment OutcomeLower ExtremityGlutaralAngiographySurgeryFemaleRadiologymedicine.symptombusinessClaudicationCardiology and Cardiovascular MedicineFollow-Up StudiesJournal of vascular surgery
researchProduct

Pulmonary embolism: risk assessment and management.

2012

Acute pulmonary embolism (PE) poses a significant burden on health and survival. Its severity ranges from asymptomatic, incidentally discovered subsegmental thrombi to massive, pressor-dependent PE complicated by cardiogenic shock and multisystem organ failure. Rapid and accurate risk stratification is therefore of paramount importance to ensure the highest quality of care. This article critically reviews currently available and emerging tools for risk-stratifying acute PE, and particularly for distinguishing between elevated (intermediate) and low risk among normotensive patients. We focus on the potential value of risk assessment strategies for optimizing severity-adjusted management. Apa…

Malemedicine.medical_specialtyVena Cava FiltersVitamin Kmedicine.medical_treatmentEarly TherapyRisk AssessmentSeverity of Illness IndexRecurrenceSeverity of illnessmedicineAmbulatory CareHumansThrombolytic TherapyIntensive care medicineAgedRandomized Controlled Trials as TopicThrombectomybusiness.industryHeparinCardiogenic shockAnticoagulantsThrombolysisLength of StayMiddle Agedmedicine.diseasePrognosisPulmonary embolismCardiac Imaging TechniquesEmbolismAcute DiseaseFemaleCardiology and Cardiovascular MedicineMultiple organ dysfunction syndromeRisk assessmentbusinessPulmonary EmbolismBiomarkersEuropean heart journal
researchProduct

Physical Function and Properties of Quadriceps Femoris Muscle in Men With Knee Osteoarthritis

2008

To examine the objective physical function of the lower extremities, to measure the properties of quadriceps femoris muscle (QFM), and to assess subjective disabilities in men with knee osteoarthritis (OA) and to compare the results with those obtained from age- and sex-matched control subjects.Cross-sectional study.Rehabilitation clinic in a university hospital.Male volunteers (n=54) (age range, 50-69y) with knee OA and randomly selected healthy, age- and sex-matched control subjects (n=53).Not applicable.Physical function evaluated with a test battery including the QFM composition measurement, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), and the RAND 36-Item…

Malemedicine.medical_specialtyWOMACMatched-Pair Analysismedicine.medical_treatmentPhysical Therapy Sports Therapy and RehabilitationOsteoarthritisSeverity of Illness IndexQuadriceps MusclePhysical medicine and rehabilitationActivities of Daily LivingSeverity of illnessArthropathymedicineHumansMuscle StrengthFunctional abilityRange of Motion ArticularAgedUltrasonographyRehabilitationbusiness.industryRehabilitationMiddle AgedOsteoarthritis Kneemedicine.diseaseQuadriceps femoris muscleCross-Sectional StudiesCase-Control StudiesQuality of LifePhysical therapyRange of motionbusinessArchives of Physical Medicine and Rehabilitation
researchProduct

Efficacy of mandibular advancement device in the treatment of obstructive sleep apnea syndrome: A randomized controlled crossover clinical trial

2015

Background Evaluation of the efficacy and safety of a mandibular advancement device (MAD) (KlearwayTM) in the treatment of mild-to-moderate obstructive sleep apnea and chronic roncopathy. Material and Methods A randomized, placebo-controlled, double blinded, and crossover clinical trial was conducted. Placebo device (PD) defined as a splint in the centric occlusion that did not induce a mandibular advancement served as a control. The mandible was advanced to the maximum tolerable distance or to a minimum of 65% of the maximum protrusion. After each sequence of treatment, patients were assessed by questionnaires, conventional polysomnography, and objective measurement of snoring at the patie…

Malemedicine.medical_specialtyanimal structuresOdontologíaPolysomnographyPlaceboSeverity of Illness Indexlaw.inventionRandomized controlled trialstomatognathic systemDouble-Blind MethodlawSeverity of illnessmedicineHumansGeneral DentistrySleep Apnea ObstructiveCross-Over Studiesmedicine.diagnostic_testbusiness.industryResearchSleep apneaMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Medically compromised patients in DentistryCrossover studyCiencias de la saludSurgeryrespiratory tract diseasesClinical trialObstructive sleep apneaTreatment OutcomeOtorhinolaryngologyAnesthesiaUNESCO::CIENCIAS MÉDICASSurgeryFemalebusinessMandibular AdvancementMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Vitamin D and cutaneous lupus erythematosus: effect of vitamin D replacement on disease severity.

2014

Background The main vitamin D source is exposure to ultraviolet radiation, which aggravates cutaneous lupus erythematosus (CLE). Objectives The aims of this study were to identify variables associated with lower serum 25-hydroxyvitamin D [25(OH)D] levels in CLE patients and assess the effect of vitamin D restoration on disease severity. Methods Vitamin D status in 60 CLE patients and 117 apparently healthy subjects was compared. We recommended oral vitamin D3 to 27 CLE patients. After one year of treatment, changes in disease severity were assessed and compared to 25 untreated CLE patients. Disease severity was measured by the Cutaneous Lupus Erythematosus Disease Area and Severity Index (C…

Malemedicine.medical_specialtybusiness.industryMiddle AgedVitamin D DeficiencyDermatologySeverity of Illness IndexCross-Sectional StudiesRheumatologyDisease severityImmunologyVitamin D and neurologyCutaneous Lupus ErythematosusLupus Erythematosus CutaneousMedicineHumansFemaleProspective StudiesVitamin DbusinessUltraviolet radiationCalcifediolLupus
researchProduct

Effect of comorbid anxiety, depressive, and personality disorders on treatment outcome of somatoform disorders

1999

Comorbid mental disorders of DSM-IV axis I and axis II have repeatedly been found to be a negative predictor for the treatment of axis I disorders, although recent contrary findings exist. Little is known about the effect of comorbidity on the therapy outcome of somatoform disorders. We compared three types of comorbidity, (1) personality disorders (PDs), (2) major depression (MDD) and anxiety (ANX) disorders, and (3) PDS and MDD and ANX, with regard to their relevance for the treatment outcome of somatoform disorders. One hundred twenty-six inpatients were assessed at least 4 weeks before admission to treatment, upon admission, and again at discharge. Somatoform, hypochondriacal, and depre…

Malemedicine.medical_specialtylcsh:RC435-571medicine.medical_treatmentDysfunctional familyPersonality DisordersSeverity of Illness Indexlcsh:Psychiatrymental disordersmedicineHumansSomatoform DisordersPsychiatryDepression (differential diagnoses)Psychiatric Status Rating ScalesAnalysis of VarianceDepressive DisorderCognitive Behavioral TherapyMiddle Agedmedicine.diseaseAnxiety DisordersPersonality disordersComorbidityPsychiatry and Mental healthClinical PsychologyTreatment OutcomeCognitive therapyAnxietyFemalemedicine.symptomPsychologyAnxiety disorderPsychopathologyClinical psychologyComprehensive Psychiatry
researchProduct

Influence of inadequate antimicrobial therapy on prognosis in elderly patients with severe urinary tract infections.

2013

Abstract Background Inadequate empirical antimicrobial therapy (IEAT) in intensive care unit (ICU) is associated with adverse outcomes. However, the influence of IEAT on prognosis for elderly patients with urinary tract infection (UTI) in non-ICU settings is unknown. Methods A retrospective cross-sectional study of elderly patients admitted to a non-ICU ward in a university hospital with a primary diagnosis of UTI over a 3-year period was done. Data relating to age, sex, background comorbidities, severity of infection, bacteremia, microorganisms isolated in urine, treatment given, length of stay and prognosis were obtained using chart review. Cases were segregated according to the adequacy …

Malemedicine.medical_specialtymedicine.drug_classUrinary systemAntibioticsComorbiditySeverity of Illness Indexlaw.inventionHospitals UniversityDrug TherapylawInternal medicineInternal MedicinemedicineHumansHospital MortalityRisk factorIntensive care medicineAPACHEAgedRetrospective StudiesAged 80 and overAPACHE IIbusiness.industryMortality rateOdds ratioLength of Staymedicine.diseasePrognosisIntensive care unitAnti-Bacterial AgentsCross-Sectional StudiesTreatment OutcomeBacteremiaUrinary Tract InfectionsFemalebusinessEuropean journal of internal medicine
researchProduct

Continuous ambulatory peritoneal dialysis as a therapeutic alternative in patients with advanced congestive heart failure.

2012

Aims Continuous ambulatory peritoneal dialysis (CAPD) has been proposed as an additional therapeutic resource for patients with advanced congestive heart failure (CHF). The objective of this study was to determine the therapeutic role of CAPD, in terms of surrogate endpoints, in the management of patients with advanced CHF and renal dysfunction. A total of 57 candidates with New York Heart Association (NYHA) class III/IV CHF, renal dysfunction (glomerular filtration rate , 60 mL/min/1.73 m 2 ), persistent fluid congestion despite loop diuretic treatment, and at least two previous hospitalizations for acute heart failure (AHF) were invited to be included in the CAPD programme; however, 25 pa…

Malemedicine.medical_specialtymedicine.drug_classmedicine.medical_treatmentRenal functionurologic and male genital diseasesKidneySeverity of Illness IndexPeritoneal dialysisPeritoneal Dialysis Continuous AmbulatoryInternal medicineSurveys and QuestionnairesmedicineAmbulatory CareHumanscardiovascular diseasesProspective StudiesRenal InsufficiencyProspective cohort studyHeart Failurebusiness.industrySurrogate endpointContinuous ambulatory peritoneal dialysisLoop diureticBrain natriuretic peptidemedicine.diseaseHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersGlomerular Filtration RateEuropean journal of heart failure
researchProduct